WAQUIA MAULTSBY: Open Payments
NPI 1902325194 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 33 payments from 14 companies in 2025. Trend: 2023 $1,027 · 2024 $735 · 2025 $899
Food & beverage: $800Education: $99
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $188 |
| Melinta Therapeutics, LLC | 3 | $154 |
| Exelixis Inc. | 2 | $116 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Alexion Pharmaceuticals, Inc. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Janssen Biotech, Inc. | 2 | $43 |
| Incyte Corporation | 2 | $42 |
| Stryker Corporation | 1 | $30 |
Products named: Rezzayo, KEYTRUDA, LifeVest, XIFAXAN, ULTOMIRIS, JARDIANCE, DARZALEX, JAKAFI.
Industry payments across NC — which companies pay providers there.
